In human cancers, overexpression of FAM111B has been reported in multiple cancer types, e.g., esophageal cancer, hepatocellular carcinoma, bladder cancer, ovarian cancer, breast cancer and lung cancer [33,34,35,36,37,38]. Here, FAM111B is linked to hepatocellular carcinoma.